DiaPharma Group, Inc.

8948 Beckett Rd.
West Chester,  OH  45069-2939

United States
http://www.diapharma.com
  • Booth: 317

We deliver solutions. DiaPharma specializes in laboratory products and analyzers for hemostasis, fatty liver disease, and cancer research. We offer assays for COVID-related coagulopathy and organ damage studies, anticoagulation measurement, bleeding disorders, liver injury markers, and more. Learn about the FDA-cleared T-TAS® 01 whole blood platelet function analyzer and the Ceveron® s100* all-in-one coagulation analyzer. *Research use only. Not for use in diagnostic procedures.


 Press Releases

  • Diapharma Group is pleased to announce that it has entered into an exclusive partnership with ZACROS. Fujimori Kogyo Co., Ltd (ZACROS), headquartered in Tokyo, Japan, and DiaPharma Group (DiaPharma), headquartered in West Chester, Ohio, have entered into an exclusive agreement for the distribution of the T-TAS®01 (Total Thrombus-formation Analysis System) products in the United States and Canada.
    The T-TAS 01 system is the world’s first instrument for the quantification of thrombus forming ability of the blood under physiological flow conditions. The T-TAS 01 with PL chip has been cleared by the US Food and Drug Administration (FDA) for the analysis and evaluation of platelet thrombus formation in patients receiving antiplatelet therapy—including aspirin, clopidogrel, prasugrel and ticagrelor—and in patients with primary hemostasis abnormalities such as Glanzmann’s thrombasthenia or von Willebrand’s Disease.


    DiaPharma is a distributor of hemostasis and coagulation products in the US and Canada. DiaPharma delivers an established customer base performing diagnostic as well as basic and clinical research in thrombosis, hemostasis, bleeding, and clotting disorders. DiaPharma has expertise with instrument sales for the hemostasis market and expects to support the launch of the T-TAS 01 instrument and consumables for sales to clinical laboratories performing testing related to coagulation and bleeding.


    DiaPharma offers a robust technical support staff and technically savvy outside salesforce that can educate users about the features of the T-TAS 01 products.Together, DiaPharma and ZACROS plan to provide solutions to researchers and clinicians in the fields of thrombosis and hemostasis.

  • September 2021, West Chester, OH – DiaPharma Group is pleased to announce our lineup of featured products during AACC 2021. Explore assays for COVID-19-associated coagulopathy, specialty hemostasis, organ injury, and SARS-CoV-2 serology. DiaPharma specializes in assays and mechanistic biomarkers for bleeding and clotting disorders, hemostasis analyzers, liver disease (Nonalcoholic Steatohepatitis, Alcoholic Hepatitis), drug-induced liver and kidney injury, and anti-cancer drug development.

    Researchers will be excited to learn about the do-it-all Ceveron® s100, for automated hemostasis research assays including ADAMTS13, FXIII, and Thrombin Generation Testing. You name it, Ceveron® s100 can do it! For research use only in the U.S. and Canada. Not for use in diagnostic procedures.

    Explore the leading edge in impaired primary hemostasis assessment with T-TAS® 01 - get results quickly with whole blood using an automated microchip flow chamber system developed for the quantitative assessment of the thrombus formation process under physiologic flow conditions. The test requires few steps to run, minimal pre-analytical handling, small sample volume, and a simple to interpret numerical cut-off makes for a simple and reliable identification of patients with a primary hemostatic disorder or to measure the efficacy of any anti-platelet therapeutic in ten minutes or less from assay start. The T-TAS® 01 is for the global evaluation of overall hemostatic ability using physiologic flow conditions, and is sensitive to both aspirin and P2Y12 inhibition, as well as the various vWD subtypes and Glanzmann Thrombasthenia. Separate reagent kit or addition of exogenous agonists aren’t necessary.

    DiaPharma delivers solutions by providing strong personal support with technical competence and experience to ensure customer expectations will be met or exceeded. Our strength is grounded in both science and staff. For more than 20 years, DiaPharma has been proud to give each of our customers a truly personalized experience—a focused, dedicated resource that understands our customers’ needs, and has the scientific and technical expertise to help customers make the best product choices. It's Not Just Support. It’s Solutions.


 Additional Info

Will your company display a new product or promote a new indication/enhanced feature(s) for an existing product in your booth?
Yes